You can enable subtitles (captions) in the video player
Of all the products in the world you don’t want to use market-based prioritisation, it’s got to be vaccines.
There’s no technology known to man now that is faster than mRNA.
Because of this monopoly or duopoly position that the sellers are in, they tend to have a high amount of market power and ability to get higher prices.
Vaccines save two to three million lives every year. But bringing them to market involves huge investment, complex science, and secretive contracts. Before the Covid-19 pandemic few people paid attention to the business models behind vaccines. The global pharmaceutical market was worth $1.3tn in 2019. Vaccines made up just 3 per cent of that, generating around $33bn